Henri Colyn Bwanika

Artiklar

Article: NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS. 2024;:1-6
The N-terminal SAM domain of the dNTPase SAMHD1 is not required for inhibition by small molecule TH6342
Dirks C; Bwanika HC; Jemth A-S; Zhang SM; Rudd SG
Article: SCIENTIFIC REPORTS. 2024;14(1):4000
Targeting autophagy as a therapeutic strategy in pediatric acute lymphoblastic leukemia
Bwanika HC; Leo IR; Struyf N; Talanti A; Aswad L; Konnur A; Bjoerklund A-C; Heyman M; Rassidakis G; Erkers T; Seashore-Ludlow B; Jafari R; Pokrovskaja Tamm K
Article: ISCIENCE. 2024;27(2):108907
Identification and evaluation of small-molecule inhibitors against the dNTPase SAMHD1 via a comprehensive screening funnel
Zhang SM; Paulin CBJ; Shu H; Yagu-Capilla M; Michel M; Marttila P; Ortis F; Bwanika HC; Dirks C; Venkatram RP; Wiita E; Jemth A-S; Almlof I; Loseva O; Hormann FM; Koolmeister T; Linde E; Lee S; Llona-Minguez S; Haraldsson M; Axelsson H; Stromberg K; Homan EJ; Scobie M; Lundback T; Helleday T; Rudd SG
Article: NPJ PRECISION ONCOLOGY. 2023;7(1):111
The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients
Akerlund E; Gudoityte G; Moussaud-Lamodiere E; Lind O; Bwanika HC; Lehti K; Salehi S; Carlson J; Wallin E; Fernebro J; Ostling P; Kallioniemi O; Joneborg U; Seashore-Ludlow B

Preprint: RESEARCH SQUARE. 2023
The Drug Efficacy Testing in Ex Vivo 3D Cultures (DETECt) platform enables rapid identification of effective drugs and drug combinations for ovarian cancer patients
Seashore-Ludlow B; Åkerlund E; Gudoityte G; Moussaud-Lamodière E; Lind O; Bwanika HC; Lehti K; Saheli S; Carlson J; Wallin E; Fernebro J; Ostling P; Kallioniemi O; Joneborg U
Preprint: BIORXIV. 2021
PcGCE is a potent elicitor of defense responses in aspen
Donev EN; Derba-Maceluch M; Liu X-K; Bwanika HC; Dobrowolska I; Thapa M; Leśniewska J; Šimura J; Tsai AY-L; Boström D; Kleczkowski LA; Eriksson ME; Ljung K; Master ER; Mellerowicz EJ